glutathione mutations in sclc patients Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes Glutathione Depletion and Stalwart Anticancer
Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances Unveiling the powerhouse: ASCL1 driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation Cancer & Metabolism Springer Nature Link Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR Mutant Lung Cancer
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




